Resection of retroperitoneal sarcoma has seen decreased morbidity over time, with acceptable long-term functional outcomes, though intraoperative and brachytherapy techniques increase toxicities.
What are the morbidity, complication rates, and functional outcomes associated with retroperitoneal sarcoma resection?
While retroperitoneal sarcoma resection carries morbidity risks, particularly in the elderly and with certain radiotherapy techniques, long-term functional and quality of life outcomes remain acceptable.
Resection of retroperitoneal sarcoma (RPS) typically involves multivisceral resection. The morbidity of RPS resection has decreased over time despite widespread adoption of radical resection. Certain patterns of resection are associated with higher complication rates and elderly patients are at increased risk of morbidity. Administration of preoperative radiotherapy does not increase morbidity, but intraoperative and brachytherapy techniques are associated with heightened toxicities. Long-term functional outcomes and quality of life scores after RPS resection are acceptable.
MacNeill et al. (Mon,) conducted a review in Retroperitoneal sarcoma (RPS). Resection of retroperitoneal sarcoma was evaluated on Surgical morbidity. Resection of retroperitoneal sarcoma has seen decreased morbidity over time, with acceptable long-term functional outcomes, though intraoperative and brachytherapy techniques increase toxicities.